Related Experiment Videos
Strategies for novel COPD therapies
1National Heart and Lung Institute, Imperial College School of Medicine, Dovehouse Street, London, SW3 6LY, UK.
Pulmonary Pharmacology & Therapeutics
|June 22, 1999
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.
The Journal of experimental medicine·1995
Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages.
Journal of immunology (Baltimore, Md. : 1950)·1995
Corticosteroid inhibition of macrophage inflammatory protein-1 alpha in human monocytes and alveolar macrophages.
The American journal of physiology·1995
Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
American journal of respiratory and critical care medicine·1995
Effects of anumigilimab, an anti-G-CSF receptor mAb, after segmental LPS challenge: A Phase 1b trial in healthy volunteers.
Pulmonary pharmacology & therapeutics·2026
Brain-derived neurotrophic factor (BDNF) signaling in respiratory disease: Mechanisms, neuroimmune crosstalk, and therapeutic implications.
Pulmonary pharmacology & therapeutics·2026
PD05, a novel neutrophil elastase inhibitor, mitigates LPS-induced acute lung injury in a preclinical model.
Pulmonary pharmacology & therapeutics·2026
The preclinical discovery and development of depemokimab for severe eosinophilic asthma.
Pulmonary pharmacology & therapeutics·2026
Synergistic induction of apoptosis in lung cancer cells via TOP2A targeting through combined dihydroartemisinin and chrysin treatment.
Pulmonary pharmacology & therapeutics·2026
Evodiamine protects against lung ischemia-reperfusion injury by attenuating SYK-associated TLR4/NLRP3 inflammasome activation and ferroptosis-related injury signatures.
Pulmonary pharmacology & therapeutics·2026